CD4 and Autoimmunity: Tumors use TGF-β in indirect methods of immune evasion: converting CD4+CD25- to CD4+CD25+ Treg cells[112] or inducing the development of a Th17 type response designed to counter autoimmunity and reduce the fraction of activated Th cells[113].